trending Market Intelligence /marketintelligence/en/news-insights/trending/Ku0zTJUFgPj2JS73y2Gu9w2 content esgSubNav
In This List

Seattle Genetics director resigns

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Seattle Genetics director resigns

John McLaughlin resigned as a director of Seattle Genetics Inc. to focus on his responsibilities as president and CEO of PDL BioPharma Inc., effective Dec. 16.

Following McLaughlin's resignation, Daniel Welch was appointed to the board's audit committee.

Welch is an independent director of Seattle Genetics.